GB0113011D0 - Biological materials and methods useful in the diagnosis and treatment of diseases - Google Patents

Biological materials and methods useful in the diagnosis and treatment of diseases

Info

Publication number
GB0113011D0
GB0113011D0 GBGB0113011.1A GB0113011A GB0113011D0 GB 0113011 D0 GB0113011 D0 GB 0113011D0 GB 0113011 A GB0113011 A GB 0113011A GB 0113011 D0 GB0113011 D0 GB 0113011D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
diseases
treatment
biological materials
methods useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0113011.1A
Other versions
GB2362385A (en
GB2362385B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824091.4A external-priority patent/GB9824091D0/en
Priority claimed from GBGB9906217.6A external-priority patent/GB9906217D0/en
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GB0205963A priority Critical patent/GB2371049B/en
Priority claimed from GB9925804A external-priority patent/GB2348203B/en
Publication of GB0113011D0 publication Critical patent/GB0113011D0/en
Publication of GB2362385A publication Critical patent/GB2362385A/en
Application granted granted Critical
Publication of GB2362385B publication Critical patent/GB2362385B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
GB0113011A 1998-11-04 1999-11-01 Non-aggregated ß-forms of prion proteins Expired - Fee Related GB2362385B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0205963A GB2371049B (en) 1998-11-04 1999-11-01 Methods of making antibodies against ß-forms of prion proteins and their uses

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9824091.4A GB9824091D0 (en) 1998-11-04 1998-11-04 Biological materials and methods useful in the diagnosis and treatment of diseases
GBGB9906217.6A GB9906217D0 (en) 1999-03-18 1999-03-18 Biological materials and methods useful in the diagnosis and treatment of diseases
GB9925804A GB2348203B (en) 1998-11-04 1999-11-01 Solube beta-forms of prion proteins, methods of preparation and use

Publications (3)

Publication Number Publication Date
GB0113011D0 true GB0113011D0 (en) 2001-07-18
GB2362385A GB2362385A (en) 2001-11-21
GB2362385B GB2362385B (en) 2002-06-19

Family

ID=27269539

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0113011A Expired - Fee Related GB2362385B (en) 1998-11-04 1999-11-01 Non-aggregated ß-forms of prion proteins

Country Status (1)

Country Link
GB (1) GB2362385B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69632056T2 (en) * 1995-09-14 2004-12-30 The Regents Of The University Of California, Oakland FOR NATIVE PRP-SC SPECIFIC ANTIBODIES
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein

Also Published As

Publication number Publication date
GB2362385A (en) 2001-11-21
GB2362385B (en) 2002-06-19

Similar Documents

Publication Publication Date Title
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
ATE349428T1 (en) PROSTAGLAND INAGONISTS AND THEIR USE IN THE TREATMENT OF BONE DISEASES
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
PT1083889E (en) TETRA-HYDROFOLANTALINE COMPOUNDS AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
EP0963219A4 (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
DE69805438D1 (en) MIXING AND CHARGING OPENING FOR MEDICAL TREATMENT
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
IL128894A0 (en) Materials and methods relating to the diagnosis and treatment of diabetes and obesity
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
AU6502199A (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
NO20020207D0 (en) Biological materials and methods useful in the diagnosis and treatment of disease
DE69636367D1 (en) T-PA POLYMORPHISM AND ITS USE IN THE RISK DIAGNOSIS OF THROMBUS ASSOCIATED DISEASES
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
GB9509461D0 (en) DNA molecules and constructs and their use in the treatment of mastitis
GB0205963D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9824091D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9908059D0 (en) Diagnosis and treatment of diseases
GB9906217D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
EP1023076A4 (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
GB9917491D0 (en) Biological materials and methods useful in the diagnosis and treastment of diseases

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20131101